From Casetext: Smarter Legal Research

Pfizer Inc. v. Sanofi Pasteur Inc.

United States Court of Appeals, Federal Circuit
Apr 26, 2024
No. 2019-1876 (Fed. Cir. Apr. 26, 2024)

Opinion

2019-1871 2019-1873 2019-1875 2019-1876 2019-2224

04-26-2024

PFIZER INC., Appellant v. SANOFI PASTEUR INC., SK CHEMICALS CO., LTD., Appellees KATHERINE K. VIDAL, UNDER SECRETARY OF COMMERCE FOR INTELLECTUAL PROPERTY AND DIRECTOR OF THE UNITED STATES PATENT AND TRADEMARK OFFICE, Intervenor


Appeals from the United States Patent and Trademark Office, Patent Trial and Appeal Board in Nos. IPR2017-02131, IPR2017-02132, IPR2017-02136, IPR2017-02138, IPR2018-00187.

MANDATE

In accordance with the judgment of this Court, entered March 5, 2024, and pursuant to Rule 41 of the Federal Rules of Appellate Procedure, the formal mandate is hereby issued.


Summaries of

Pfizer Inc. v. Sanofi Pasteur Inc.

United States Court of Appeals, Federal Circuit
Apr 26, 2024
No. 2019-1876 (Fed. Cir. Apr. 26, 2024)
Case details for

Pfizer Inc. v. Sanofi Pasteur Inc.

Case Details

Full title:PFIZER INC., Appellant v. SANOFI PASTEUR INC., SK CHEMICALS CO., LTD.…

Court:United States Court of Appeals, Federal Circuit

Date published: Apr 26, 2024

Citations

No. 2019-1876 (Fed. Cir. Apr. 26, 2024)